These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 10913166)
21. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. Wasylyk C; Gutman A; Nicholson R; Wasylyk B EMBO J; 1991 May; 10(5):1127-34. PubMed ID: 1850695 [TBL] [Abstract][Full Text] [Related]
22. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. Baillat D; Bègue A; Stéhelin D; Aumercier M J Biol Chem; 2002 Aug; 277(33):29386-98. PubMed ID: 12034715 [TBL] [Abstract][Full Text] [Related]
23. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581. Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371 [TBL] [Abstract][Full Text] [Related]
24. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation. Kawagoe H; Potter M; Ellis J; Grosveld GC Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392 [TBL] [Abstract][Full Text] [Related]
25. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. Kwiatkowski BA; Bastian LS; Bauer TR; Tsai S; Zielinska-Kwiatkowska AG; Hickstein DD J Biol Chem; 1998 Jul; 273(28):17525-30. PubMed ID: 9651344 [TBL] [Abstract][Full Text] [Related]
26. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Maki K; Arai H; Waga K; Sasaki K; Nakamura F; Imai Y; Kurokawa M; Hirai H; Mitani K Mol Cell Biol; 2004 Apr; 24(8):3227-37. PubMed ID: 15060146 [TBL] [Abstract][Full Text] [Related]
32. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001 [TBL] [Abstract][Full Text] [Related]
33. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877 [TBL] [Abstract][Full Text] [Related]
34. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659 [TBL] [Abstract][Full Text] [Related]
35. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. Buttice G; Kurkinen M J Biol Chem; 1993 Apr; 268(10):7196-204. PubMed ID: 8463255 [TBL] [Abstract][Full Text] [Related]
36. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Guidez F; Petrie K; Ford AM; Lu H; Bennett CA; MacGregor A; Hannemann J; Ito Y; Ghysdael J; Greaves M; Wiedemann LM; Zelent A Blood; 2000 Oct; 96(7):2557-61. PubMed ID: 11001911 [TBL] [Abstract][Full Text] [Related]
37. Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. Van Rompaey L; Dou W; Buijs A; Grosveld G Neoplasia; 1999 Dec; 1(6):526-36. PubMed ID: 10935500 [TBL] [Abstract][Full Text] [Related]